IsoFlex Pacing Leads
ABBOTT MEDICAL · Decision date Nov 20, 2025
What did the FDA approve?
FDA records P960030/S083 as a supplement to PMA P960030, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Nov 20, 2025.
FDA approval order statement
approval for model line extensions for the Zenex MRI & Zenus MRI families of pacemakers and updated labeling for cardiac leads and additional pacemaker models
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 20, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P960030/S083
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- NVN
- Decision code
- APPR
- Decision date
- Nov 20, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Applicant
- Abbott Medical
- Product code
- NVN
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P960030/S081 · Related supplement
IsoFlex (1944)
P960030/S083 received
Application receipt date recorded by FDA.
P960030/S083 · FDA decision
Normal 180 Day Track
P960030/S084 · Related supplement
UltiPace Low Voltage LPA1231, Tendril Low Voltage 2088TC, OptiSense Low Voltage 1999, Isoflex Low Voltage 1944/1948, Ten
P960030/S085 · Related supplement
IsoFlex Leads
Timeline entries are records held by MedtechLedger for P960030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
IsoFlex (1944)P960030/S081 | ABBOTT MEDICAL | PMA supplement | Aug 27, 2025 | FDA |
IsoFlexP960030/S080 | ABBOTT MEDICAL | PMA supplement | Feb 19, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 11, 2026 | FDA | |
IsoFlex LeadsP960030/S085 | ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
SelectSecure Lead 3830P030036/S161 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Aug 5, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jun 26, 2026 | FDA | |
SelectSecure Lead (3830)P030036/S160 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Jun 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91335
Sources and methodology
- Original FDA record: P960030/S083
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




